Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Verrica Pharmaceuticals NASDAQ VRCA
$6.98 0.08 1.15%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

323.25M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
297.28M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.12
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
46.31M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-4.64 %
Upcoming events Verrica Pharmaceuticals All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Verrica Pharmaceuticals

Stock analysis Verrica Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-4.86 -86.91
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
16.36 12.24
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-4.77 -27.23
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.42 0.61
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-336.46 -1.16

Price change Verrica Pharmaceuticals per year

7.05$ 18.42$
Min Max

Summary analysis Verrica Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Verrica Pharmaceuticals

Revenue and net income Verrica Pharmaceuticals

All parameters
Stock news Verrica Pharmaceuticals All news
15 December 2023 в 14:30

Verrica Pharmaceuticals Shares Rise After Partner Reports Trial Results

15 December 2023 в 14:30

Verrica Pharmaceuticals Shares Rise After Partner Reports Trial Results

22 July 2023 в 02:05

Stocks to Watch: AMC Entertainment, Becton Dickinson and Verrica Pharmaceuticals

22 July 2023 в 02:05

Stocks to Watch: AMC Entertainment, Becton Dickinson and Verrica Pharmaceuticals

22 July 2023 в 00:30

Verrica Pharmaceuticals Shares Down 6.8% Following FDA Approval of Topical Solution

22 July 2023 в 00:25

Verrica Pharmaceuticals Shares Down 6.8% Following FDA Approval of Topical Solution

21 July 2023 в 23:45

Verrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA Approval

21 July 2023 в 23:45

Verrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA Approval

30 June 2022 в 17:52

Verrica Pharmaceuticals Shares Drop 15% After Public Offering Prices

30 June 2022 в 17:52

Verrica Pharmaceuticals Shares Drop 15% After Public Offering Prices

30 June 2022 в 13:31

Verrica Pharmaceuticals Shares Drop 7% After Public Offering Prices

30 June 2022 в 13:31

Verrica Pharmaceuticals Shares Drop 7% After Public Offering Prices

25 May 2022 в 17:56

Verrica Pharmaceuticals Shares Plumb New Depths After VP-102 Setback >VRCA

25 May 2022 в 17:55

Verrica Pharmaceuticals Shares Plumb New Depths After VP-102 Setback >VRCA

29 November 2021 в 15:50

Verrica Pharmaceuticals Refiles FDA Application for VP-102 >VRCA

29 November 2021 в 15:50

Verrica Pharmaceuticals Refiles FDA Application for VP-102 >VRCA

21 September 2021 в 17:59

Verrica Pharmaceuticals Shares Drop 17% After FDA Complete Response Letter

21 September 2021 в 17:59

Verrica Pharmaceuticals Shares Drop 17% After FDA Complete Response Letter

About company Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; which has completed phase II clinical trial for treating common warts; and that is in phase II clinical trial for the treatment of external genital warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Address:
44 West Gay Street, West Chester, PA, United States, 19380
Company name: Verrica Pharmaceuticals
Issuer ticker: VRCA
ISIN: US92511W1080
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-06-15
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.verrica.com

On which stock exchange are Verrica Pharmaceuticals (VRCA) stocks traded?

Verrica Pharmaceuticals (VRCA) stocks are traded on NASDAQ.

What is the ticker of Verrica Pharmaceuticals stocks (VRCA)?

The stock ticker of Verrica Pharmaceuticals’s stocks or in other words, the code is VRCA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Verrica Pharmaceuticals (VRCA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Verrica Pharmaceuticals (VRCA) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Verrica Pharmaceuticals (VRCA) stocks traded?

Verrica Pharmaceuticals (VRCA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Verrica Pharmaceuticals (VRCA) stocks today?

The current price of Verrica Pharmaceuticals stocks on 20.04.2024 is 6.98 dollars. per share.

What is the dynamics of Verrica Pharmaceuticals (VRCA) stocks from the beginning of the year?

Verrica Pharmaceuticals (VRCA) quotes have increased by 2.5% from the beginning of the year up to 6.98 dollars. per 1 stocks.

How much did Verrica Pharmaceuticals (VRCA) stocks increase in апреле 2024?

This month Verrica Pharmaceuticals (VRCA) quotes have increased by 17.91% to 6.98 dollars. per share.

How much are Verrica Pharmaceuticals (VRCA) stocks worth?

Today, on October, 20.04.2024 Verrica Pharmaceuticals’s (VRCA) stocks cost 6.98 dollars..

What is the market capitalization of Verrica Pharmaceuticals (VRCA)?

Capitalization is the market value of Verrica Pharmaceuticals (VRCA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 20.04.2024, the market capitalization of Verrica Pharmaceuticals (VRCA) is estimated at about 323253949 dollars.